A comparison of the effects of isoflurane and desflurane on the neuromuscular effects of mivacurium

Anaesthesia

Volumn 51, Issue 6, 1996, Pages 547-550

  Kumar, N ^a   Mirakhur, R K ^a   Symington, M J ^a   Loan, P B ^a   Connolly, F M ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Anaesthetics; volatile, desflurane, isoflurane; Neuromuscular relaxants; mivacurium

Indexed keywords

DESFLURANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG POTENCY; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NEUROMUSCULAR BLOCKING; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ANESTHETICS, INHALATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; HUMANS; ISOFLURANE; ISOQUINOLINES; MALE; MIDDLE AGED; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; TIME FACTORS;

EID: 0029990510     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.1996.tb12561.x     Document Type: Article

References (22)

1. MILLER RD, WAY WL, DONLAN WM, STEVENS WC, EGER EI. The dependence of pancuronium and d-tubocurarine-induced neuromuscular blockades on alveolar concentrations of halothane and forane. Anesthesiology 1972; 37: 573-81.
2. RUPP SM, MILLER RD, GENCARELLI PJ. Vecuronium-induced neuromuscular blockade during enflurane, isoflurane and halothane anesthesia in humans. Anesthesiology 1984; 60: 102-5.
3. WEBER S, BRANDOM BW, POWERS DM, SARNER JB, WOELFEL SK, COOK DR, FOSTER VJ, MCNULTY BF, WEAKLY JN. Mivacurium Chloride (BW B1090U)-induced neuromuscular blockade during nitrous oxide-isoflurane and nitrous oxide-narcotic anesthesia in adult surgical patients. Anesthesia and Analgesia 1988; 67: 495-9.
4. EGER EI II. Partition coefficients of I-653 in human blood, saline and olive oil. Anesthesia and Analgesia 1987; 66: 971-73.
5. YASUDA N, LOCKHART SH, EGER EI II, WEISKOPF RB, JOHNSON BH, FREIRE BA, FASSOULAKI A. Kinetics of desflurane, isoflurane and halothane in humans. Anesthesiology 1991; 74: 489-98.
6. CALDWELL JE, LASTER MJ, MAGORIAN T, HEIER T, YASUDA N, LYNAM P, EGER EI, WEISKOPF RB. The neuromuscular effects of desflurane, alone and combined with pancuronium or succinylcholine in humans. Anesthesiology 1991; 74: 412-18.
7. LEE C, TSAI S-K, KWAN W-F, CHEN ML. Desflurane potentiates atracurium in humans: a comparative study with isoflurane. Journal of Clinical Anesthesia 1992; 4: 448-54.
8. GHOURI AF, WHITE PF. Comparative effects of desflurane and isoflurane on vecuronium induced neuromuscular blockade. Journal of Clinical Anesthesia 1992; 4: 34-8.
9. STEVENS WC, DOLAN WM, GIBBONS RT, WHITE A, EGER EI II, MILLER RD, DE JONG RH, ELASHOFF RM. Minimum alveolar concentration (MAC) of isoflurane with and without nitrous oxide in patients of various ages. Anesthesiology 1975; 42: 197-200.
10. RAMPIL IJ, LOCKHART SH, ZWASS MS, PETERSON N, YASUDA N, EGER EI II, WEISKOPF RB, DAMASK MC. Clinical character-istics of desflurane in surgical patients: minimum alveolar concentration. Anesthesiology 1991; 74: 429-33.
11. GIBSON FM, MIRAKHUR RK, CLARKE RSJ, LAVERY GG. Potency of atracurium; a comparison of single dose and cumulative dose techniques. Anesthesiology 1985; 62: 657-9.
12. GIBSON FM, MIRAKHUR RK, CLARKE RSJ, LAVERY GG. Comparison of cumulative and single bolus dose techniques for determining the potency of vecuronium. British Journal of Anaesthesia 1985; 57: 1060-2.
13. ARMITAGE P. Statistical methods in medical research. Oxford: Blackwell Scientific Publications 1971.
14. COOPER RA, MIRAKHUR RK, ELLIOTT P, MCCARTHY GJ. Estimation of potency of Org 9426 using two different modes of nerve stimulation. Canadian Journal of Anaesthesia 1992; 39: 139-42.
15. MADDINENI VR, MIRAKHUR RK, COOPER R, MCCOY E. Potency estimation of mivacurium; comparison of two different modes of nerve stimulation. British Journal of Anaesthesia 1993; 70: 694-5.
16. FROM RP, PEARSON KS, CHOI WW, ABOU-DONIA M, SOKOLL MD. Neuromuscular and cardiovascular effects of mivacurium chloride (BW B1090U) during nitrous oxide-fentanyl-thiopentone and nitrous oxide-halothane anaesthesia. British Journal of Anaesthesia 1990; 64: 193-8.
17. SAVARESE JJ, ALI HH, BASTA SJ, EMBREE PB, SCOTT RP, SUNDER N, WEAKLY JN, WASTILA WB, EL-SAYAD HA. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug. Anesthesiology 1988; 68: 723-32.
18. CHOI WW, MEHTA MP, MURRAY DJ, SOKOLL MD, FORBES RB, GERGIS SD, ABOU-DONIA M, KIRCHNER J. Neuromuscular and cardiovascular effects of mivacurium chloride in surgical patients receiving nitrous oxide-narcotic or nitrous oxide-isotlurane anaesthesia. Canadian Journal of Anaesthesia 1989; 36: 641-50.
19. MADDINENI VR, MIRAKHUR RK, MCCOY EP, FEE JPH, CLARKE RSJ. Neuromuscular effects and intubating conditions following mivacurium: a comparison with suxamethonium. Anaesthesia 1993; 48: 940-5.
20. WAUD BE, WAUD DR. Effects of volatile anaesthetics on directly and indirectly stimulated skeletal muscle. Anesthesiology 1979; 50: 103-10.
21. BOWMAN WC. The neuromuscular junction: recent developments. European Journal of Anaesthesiology 1985; 2: 59-93.
22. MILLER RD, EGER EI, WAY WL, STEVENS WC, DOLAN WM. Comparative neuromuscular effects of forane and halothane alone and in combination with d-tubocurarine in man. Anesthesiology 1971; 35: 38-42.